Related Experiment Video
Updated: Sep 4, 2025
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Research progress in targeted therapy and immunotherapy for gastric cancer
1Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Abstract:
Gastric cancer (GC) is one of the most common malignant tumors worldwide. Its incidence ranks the 5th among all malignant tumors globally, and it is the 3rd leading cause of death among patients with cancer. Surgical treatment is the first choice in clinical practice. However, targeted therapy, immunotherapy, and other treatment methods have also become research hotspots at home and abroad with the development of individualized precision therapy in recent years, besides traditional radiotherapy and chemotherapy. At present, targeted therapy and immunotherapy are methods used for treating GC, and they have important clinical application value and prospects. This study aimed to review the research progress of targeted therapy and immunotherapy for GC, focusing on its mechanism of action and related important clinical trials, hoping to provide references for the clinical treatment of GC.
Insights
Gastric cancer (GC) treatment is advancing beyond surgery. Targeted therapy and immunotherapy show promise, offering new hope and improved clinical outcomes for patients with this common malignancy.
Area of Science:
- Oncology
- Gastroenterology
- Cancer Research
Background:
- Gastric cancer (GC) is a leading cause of cancer death globally, ranking 5th in incidence.
- Surgery remains the primary treatment, but novel therapies are emerging.
- Individualized precision medicine drives research into advanced treatment options.
Purpose of the Study:
- To review the latest research on targeted therapy and immunotherapy for gastric cancer.
- To elucidate the mechanisms of action for these novel treatments.
- To summarize key clinical trials and their implications for GC treatment.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of mechanisms of action for targeted and immune-based therapies.
- Synthesis of data from significant clinical trials in gastric cancer.
Main Results:
- Targeted therapy and immunotherapy represent significant advancements in GC treatment.
- These therapies offer improved clinical application value and promising future prospects.
- Understanding mechanisms and trial outcomes is crucial for clinical decision-making.
Conclusions:
- Targeted therapy and immunotherapy are vital components of modern gastric cancer management.
- Continued research and clinical trials are essential for optimizing patient outcomes.
- These innovative treatments provide valuable references for current and future GC clinical practice.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...